A Bioartificial Liver Device Secreting Interleukin-1 Receptor Antagonist for the Treatment of Hepatic Failure in Rats
- 31 January 2007
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 137 (1), 130-140
- https://doi.org/10.1016/j.jss.2006.08.009
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Treatment of Fulminant Hepatic Failure in Rats Using a Bioartificial Liver Device Containing Porcine Hepatocytes Producing Interleukin-1 Receptor AntagonistTissue Engineering, 2006
- In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in ratsGastroenterology, 2003
- Transfer Of The Interleukin-1 Receptor Antagonist Gene Into Rat Liver Abrogates Hepatic Ischemia-Reperfusion InjuryTransplantation, 2002
- Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-xL proteinsOncogene, 2002
- Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptorsOncogene, 2000
- Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient miceHepatology, 2000
- Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodentHepatology, 1997
- Circulating proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitisClinical and Experimental Immunology, 1994
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988